AirSculpt Technologies (AIRS) vs DocGo (DCGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
DocGo (DCGO) has outperformed AirSculpt Technologies (AIRS) over the past year, losing 81.9% versus a loss of 83.9%. Over five years, AIRS leads with a -95.1% price change compared with -97.7% for DCGO. AirSculpt Technologies is the larger company by market cap ($43.7 million vs $17.3 million), about 2.5 times the size.
AirSculpt Technologies converts more of its revenue into profit, with a net margin of -7.7% versus -56.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIRS | DCGO |
|---|---|---|
| Share price | $0.5907 | $0.175 |
| Market cap | $43.67M | $17.32M |
| 1-day change | -9.72% | +1.98% |
| YTD return | -70.17% | -80.07% |
| 1-year return | -83.86% | -81.92% |
| 5-year return | -95.10% | -97.71% |
| Forward P/E | — | 34.75 |
| EPS (TTM) | $-0.12 | $-1.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $151.82M | $322.20M |
| Revenue growth (YoY) | -15.82% | -47.74% |
| Net income (latest FY) | $-11.67M | $-182.40M |
| Gross margin | 59.37% | — |
| Operating margin | -7.61% | -55.26% |
| Net margin | -7.68% | -56.61% |
| 52-week high | $5.79 | $1.10 |
| 52-week low | $0.516 | $0.167 |
| Distance from 52-week high | -89.80% | -84.09% |
| Analyst consensus | none | buy |
| Avg. price target upside | +661.81% | +974.29% |
| Average volume | 1.27M | 729.51K |
| Shares outstanding | 73.93M | 98.99M |
| Employees | 330 | 2,537 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AirSculpt Technologies is about 2.5 times larger than DocGo by market value ($43.67M vs $17.32M).
- AirSculpt Technologies is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -56.6 cents for DocGo.
- AirSculpt Technologies grew revenue faster in its latest fiscal year (-15.82% vs -47.74%).
About AirSculpt Technologies
AIRS stock →AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Health Care · Medical/Nursing Services · 330 employees
About DocGo
DCGO stock →DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom.
Health Care · Medical/Nursing Services · 2,537 employees
AIRS vs DCGO FAQ
Which is bigger, AirSculpt Technologies or DocGo?
AirSculpt Technologies (AIRS) is larger, with a market capitalization of $43.67M compared with $17.32M for DocGo (DCGO).
Which stock has performed better over the past year, AIRS or DCGO?
DCGO returned -81.92% over the past 12 months, compared with -83.86% for AIRS (price return, excluding dividends). Past performance does not predict future results.
Are AirSculpt Technologies and DocGo in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.